Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NAYZILAM 5 MG NASAL SPRAY

midazolam
$327.6380per EA
High Outlier
DEA Schedule CIV

Strength

5 mg/.1mL

Manufacturer

UCB, Inc.

NDC

50474050015

Classification

Brand

Dosage Form

SPRAY

Route

NASAL

Last Updated

1/1/2026

Active Ingredients

MIDAZOLAM

Approval Type

New Drug (NDA)

FDA Application

NDA211321

On Market Since

5/17/2019

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.6%

1Y

+2.5%

3Y

+9.4%

5Y

+24.2%

All

+24.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

KLONOPIN 0.5 MG TABLET
Brand
61269060510•H2-Pharma LLC
$2.6797
per EA
KLONOPIN 1 MG TABLET
Brand
61269061010•H2-Pharma LLC
$3.0637
per EA
KLONOPIN 2 MG TABLET
Brand
61269062010•H2-Pharma LLC
$4.2603
per EA
HALCION 0.25 MG TABLET
Brand
00009001755•Pharmacia & Upjohn Company LLC
$5.3212
per EA
HALCION 0.25 MG TABLET
Brand
00009001758•Pharmacia & Upjohn Company LLC
$5.3212
per EA
XANAX 0.25 MG TABLET
Brand
00009002901•Pharmacia & Upjohn Company LLC
$5.6478
per EA
XANAX 0.25 MG TABLET
Brand
00009002902•Pharmacia & Upjohn Company LLC
$5.6478
per EA
XANAX 0.25 MG TABLET
Brand
58151045201•Viatris Specialty LLC
$5.6478
per EA
XANAX 0.25 MG TABLET
Brand
58151045205•Viatris Specialty LLC
$5.6478
per EA
XANAX 0.5 MG TABLET
Brand
00009005501•Pharmacia & Upjohn Company LLC
$7.0354
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy